Siemens Healthineers received the CE mark for two of its tests: the FTD SARS-CoV-2/FluA/FluB/HRSV Assay and the Clinitest Rapid COVID-19 + Influenza Antigen Test.

The FTD SARS-CoV-2/FluA/FluB/HRSV Assay is a polymerase chain reaction (PCR) test that allows for semi-automated molecular testing for several seasonal respiratory pathogens. It detects and distinguishes SARS-CoV-2, Influenza A, Influenza B and HRSV A/B. 

The Clinitest Rapid COVID-19 + Influenza Antigen Test uses a single nasopharyngeal swab sample and can differentiate between SARS-CoV-2, Influenza A and Influenza B infections.

Both tests are designed to enable effective management of seasonal respiratory testing during and beyond the current COVID-19 pandemic, the company said.